25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Healius Ltd
Buy, Hold or Sell?

Let's analyze Healius together

I guess you are interested in Healius Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Healius Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Healius Ltd

I send you an email if I find something interesting about Healius Ltd.

1. Quick Overview

1.1. Quick analysis of Healius (30 sec.)










1.2. What can you expect buying and holding a share of Healius? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
A$1.43
Expected worth in 1 year
A$-1.13
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$-2.56
Return On Investment
-148.2%

For what price can you sell your share?

Current Price per Share
A$1.73
Expected price per share
A$1.58 - A$1.8175
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Healius (5 min.)




Live pricePrice per Share (EOD)
A$1.73
Intrinsic Value Per Share
A$-2.55 - A$5.60
Total Value Per Share
A$-1.12 - A$7.04

2.2. Growth of Healius (5 min.)




Is Healius growing?

Current yearPrevious yearGrowGrow %
How rich?$702.7m$1b-$314.3m-44.7%

How much money is Healius making?

Current yearPrevious yearGrowGrow %
Making money-$436.1m-$252.9m-$183.1m-42.0%
Net Profit Margin-37.0%-21.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Healius (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#41 / 137

Most Revenue
#14 / 137

Most Profit
#136 / 137
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Healius?

Welcome investor! Healius's management wants to use your money to grow the business. In return you get a share of Healius.

First you should know what it really means to hold a share of Healius. And how you can make/lose money.

Speculation

The Price per Share of Healius is A$1.73. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Healius.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Healius, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$1.43. Based on the TTM, the Book Value Change Per Share is A$-0.64 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.57 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Healius.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.60-34.7%-0.60-34.7%-0.34-19.8%-0.14-7.9%-0.09-5.3%
Usd Book Value Change Per Share-0.43-25.0%-0.43-25.0%-0.39-22.3%-0.19-10.9%-0.12-7.2%
Usd Dividend Per Share0.000.0%0.000.0%0.031.8%0.042.3%0.052.7%
Usd Total Gains Per Share-0.43-25.0%-0.43-25.0%-0.35-20.5%-0.15-8.6%-0.08-4.5%
Usd Price Per Share1.01-1.01-1.99-2.02-2.21-
Price to Earnings Ratio-1.69--1.69--5.81-8.53-70.87-
Price-to-Total Gains Ratio-2.34--2.34--5.61--37.87-23.21-
Price to Book Ratio1.05-1.05-1.42-1.30-1.26-
Price-to-Total Gains Ratio-2.34--2.34--5.61--37.87-23.21-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.168269
Number of shares855
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.04
Usd Book Value Change Per Share-0.43-0.19
Usd Total Gains Per Share-0.43-0.15
Gains per Quarter (855 shares)-370.14-127.30
Gains per Year (855 shares)-1,480.56-509.21
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1481-1491134-643-519
20-2961-2972267-1285-1028
30-4442-4453401-1928-1537
40-5922-5934534-2571-2046
50-7403-7415668-3214-2555
60-8883-8896801-3856-3064
70-10364-10377935-4499-3573
80-11844-118581068-5142-4082
90-13325-133391202-5785-4591
100-14806-148201335-6427-5100

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%6.04.00.060.0%23.04.00.085.2%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%4.06.00.040.0%20.07.00.074.1%
Dividend per Share0.00.01.00.0%2.00.01.066.7%4.00.01.080.0%9.00.01.090.0%26.00.01.096.3%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%5.05.00.050.0%21.06.00.077.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Healius Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.641-0.6410%-0.572-11%-0.278-57%-0.183-71%
Book Value Per Share--1.4331.4330%2.074-31%2.274-37%2.594-45%
Current Ratio--0.5000.5000%0.547-9%0.692-28%0.752-34%
Debt To Asset Ratio--0.6510.6510%0.588+11%0.572+14%0.478+36%
Debt To Equity Ratio--1.8661.8660%1.425+31%1.371+36%0.999+87%
Dividend Per Share----0%0.047-100%0.058-100%0.068-100%
Eps---0.889-0.8890%-0.507-43%-0.202-77%-0.136-85%
Free Cash Flow Per Share--0.2390.2390%0.354-32%0.475-50%0.324-26%
Free Cash Flow To Equity Per Share---0.077-0.0770%-0.151+95%-0.063-19%0.005-1575%
Gross Profit Margin--1.9921.9920%1.536+30%0.691+188%-5.430+373%
Intrinsic Value_10Y_max--5.603--------
Intrinsic Value_10Y_min---2.552--------
Intrinsic Value_1Y_max--0.494--------
Intrinsic Value_1Y_min--0.179--------
Intrinsic Value_3Y_max--1.537--------
Intrinsic Value_3Y_min--0.165--------
Intrinsic Value_5Y_max--2.641--------
Intrinsic Value_5Y_min---0.258--------
Market Cap1256210076.160+13%1089199488.0001089199488.0000%2137227235.354-49%2170934328.842-50%2371855327.729-54%
Net Profit Margin---0.370-0.3700%-0.219-41%-0.095-74%-0.064-83%
Operating Margin--0.0230.0230%0.056-59%0.095-76%0.086-74%
Operating Ratio--0.9770.9770%0.944+3%0.905+8%0.959+2%
Pb Ratio1.207+13%1.0471.0470%1.419-26%1.297-19%1.257-17%
Pe Ratio-1.945-15%-1.687-1.6870%-5.811+245%8.529-120%70.873-102%
Price Per Share1.730+13%1.5001.5000%2.943-49%2.990-50%3.266-54%
Price To Free Cash Flow Ratio7.228+13%6.2676.2670%8.310-25%6.481-3%15.492-60%
Price To Total Gains Ratio-2.699-15%-2.340-2.3400%-5.608+140%-37.871+1519%23.215-110%
Quick Ratio--0.4130.4130%0.455-9%0.419-2%0.515-20%
Return On Assets---0.217-0.2170%-0.103-53%-0.050-77%-0.035-84%
Return On Equity---0.621-0.6210%-0.249-60%-0.144-77%-0.090-86%
Total Gains Per Share---0.641-0.6410%-0.525-18%-0.220-66%-0.115-82%
Usd Book Value--702784710.000702784710.0000%1017136860.000-31%1115203926.000-37%1272217929.000-45%
Usd Book Value Change Per Share---0.433-0.4330%-0.386-11%-0.188-57%-0.124-71%
Usd Book Value Per Share--0.9680.9680%1.401-31%1.536-37%1.752-45%
Usd Dividend Per Share----0%0.032-100%0.039-100%0.046-100%
Usd Eps---0.601-0.6010%-0.342-43%-0.136-77%-0.092-85%
Usd Free Cash Flow--117367140.000117367140.0000%173687160.000-32%232762404.000-50%158688747.000-26%
Usd Free Cash Flow Per Share--0.1620.1620%0.239-32%0.321-50%0.219-26%
Usd Free Cash Flow To Equity Per Share---0.052-0.0520%-0.102+95%-0.042-19%0.004-1575%
Usd Market Cap848318664.431+13%735536414.246735536414.2460%1443269552.034-49%1466031952.267-50%1601713902.815-54%
Usd Price Per Share1.168+13%1.0131.0130%1.988-49%2.019-50%2.206-54%
Usd Profit---436108740.000-436108740.0000%-252967380.000-42%-99849858.000-77%-68961973.582-84%
Usd Revenue--1179208860.0001179208860.0000%1152669570.000+2%1242511482.000-5%1171706277.000+1%
Usd Total Gains Per Share---0.433-0.4330%-0.354-18%-0.149-66%-0.078-82%
 EOD+4 -4MRQTTM+0 -0YOY+8 -285Y+6 -3010Y+6 -30

3.3 Fundamental Score

Let's check the fundamental score of Healius Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.945
Price to Book Ratio (EOD)Between0-11.207
Net Profit Margin (MRQ)Greater than0-0.370
Operating Margin (MRQ)Greater than00.023
Quick Ratio (MRQ)Greater than10.413
Current Ratio (MRQ)Greater than10.500
Debt to Asset Ratio (MRQ)Less than10.651
Debt to Equity Ratio (MRQ)Less than11.866
Return on Equity (MRQ)Greater than0.15-0.621
Return on Assets (MRQ)Greater than0.05-0.217
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Healius Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.532
Ma 20Greater thanMa 501.720
Ma 50Greater thanMa 1001.632
Ma 100Greater thanMa 2001.531
OpenGreater thanClose1.745
Total5/5 (100.0%)

4. In-depth Analysis

4.1 About Healius Ltd

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics, QML Pathology, TML Pathology, Abbott Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories, medical centers, patient collection centers, and community imaging centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

Fundamental data was last updated by Penke on 2024-10-02 06:07:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Healius earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Healius to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -37.0% means that $-0.37 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Healius Ltd:

  • The MRQ is -37.0%. The company is making a huge loss. -2
  • The TTM is -37.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-37.0%TTM-37.0%0.0%
TTM-37.0%YOY-21.9%-15.0%
TTM-37.0%5Y-9.5%-27.4%
5Y-9.5%10Y-6.4%-3.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-37.0%-2.0%-35.0%
TTM-37.0%-7.0%-30.0%
YOY-21.9%-3.6%-18.3%
5Y-9.5%-2.7%-6.8%
10Y-6.4%-0.3%-6.1%
4.3.1.2. Return on Assets

Shows how efficient Healius is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Healius to the Diagnostics & Research industry mean.
  • -21.7% Return on Assets means that Healius generated $-0.22 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Healius Ltd:

  • The MRQ is -21.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -21.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-21.7%TTM-21.7%0.0%
TTM-21.7%YOY-10.3%-11.4%
TTM-21.7%5Y-5.0%-16.7%
5Y-5.0%10Y-3.5%-1.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.7%-0.7%-21.0%
TTM-21.7%-1.2%-20.5%
YOY-10.3%-1.0%-9.3%
5Y-5.0%-0.2%-4.8%
10Y-3.5%-0.4%-3.1%
4.3.1.3. Return on Equity

Shows how efficient Healius is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Healius to the Diagnostics & Research industry mean.
  • -62.1% Return on Equity means Healius generated $-0.62 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Healius Ltd:

  • The MRQ is -62.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -62.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-62.1%TTM-62.1%0.0%
TTM-62.1%YOY-24.9%-37.2%
TTM-62.1%5Y-14.4%-47.6%
5Y-14.4%10Y-9.0%-5.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-62.1%-0.3%-61.8%
TTM-62.1%-0.5%-61.6%
YOY-24.9%-0.1%-24.8%
5Y-14.4%-1.0%-13.4%
10Y-9.0%-1.5%-7.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Healius Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Healius is operating .

  • Measures how much profit Healius makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Healius to the Diagnostics & Research industry mean.
  • An Operating Margin of 2.3% means the company generated $0.02  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Healius Ltd:

  • The MRQ is 2.3%. The company is operating less efficient.
  • The TTM is 2.3%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ2.3%TTM2.3%0.0%
TTM2.3%YOY5.6%-3.3%
TTM2.3%5Y9.5%-7.2%
5Y9.5%10Y8.6%+0.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3%-14.4%+16.7%
TTM2.3%-13.2%+15.5%
YOY5.6%1.8%+3.8%
5Y9.5%0.7%+8.8%
10Y8.6%3.8%+4.8%
4.3.2.2. Operating Ratio

Measures how efficient Healius is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.98 means that the operating costs are $0.98 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Healius Ltd:

  • The MRQ is 0.977. The company is less efficient in keeping operating costs low.
  • The TTM is 0.977. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.977TTM0.9770.000
TTM0.977YOY0.944+0.033
TTM0.9775Y0.905+0.072
5Y0.90510Y0.959-0.054
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9771.314-0.337
TTM0.9771.283-0.306
YOY0.9441.294-0.350
5Y0.9051.240-0.335
10Y0.9591.190-0.231
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Healius Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Healius is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 0.50 means the company has $0.50 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Healius Ltd:

  • The MRQ is 0.500. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.500. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.500TTM0.5000.000
TTM0.500YOY0.547-0.047
TTM0.5005Y0.692-0.192
5Y0.69210Y0.752-0.061
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5002.015-1.515
TTM0.5002.134-1.634
YOY0.5472.568-2.021
5Y0.6922.649-1.957
10Y0.7523.202-2.450
4.4.3.2. Quick Ratio

Measures if Healius is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Healius to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.41 means the company can pay off $0.41 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Healius Ltd:

  • The MRQ is 0.413. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.413. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.413TTM0.4130.000
TTM0.413YOY0.455-0.042
TTM0.4135Y0.419-0.007
5Y0.41910Y0.515-0.095
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4131.200-0.787
TTM0.4131.282-0.869
YOY0.4551.693-1.238
5Y0.4192.038-1.619
10Y0.5152.367-1.852
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Healius Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Healius assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Healius to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.65 means that Healius assets are financed with 65.1% credit (debt) and the remaining percentage (100% - 65.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Healius Ltd:

  • The MRQ is 0.651. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.651. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.651TTM0.6510.000
TTM0.651YOY0.588+0.063
TTM0.6515Y0.572+0.079
5Y0.57210Y0.478+0.094
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6510.440+0.211
TTM0.6510.438+0.213
YOY0.5880.359+0.229
5Y0.5720.417+0.155
10Y0.4780.443+0.035
4.5.4.2. Debt to Equity Ratio

Measures if Healius is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Healius to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 186.6% means that company has $1.87 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Healius Ltd:

  • The MRQ is 1.866. The company is just able to pay all its debts with equity.
  • The TTM is 1.866. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.866TTM1.8660.000
TTM1.866YOY1.425+0.441
TTM1.8665Y1.371+0.495
5Y1.37110Y0.999+0.372
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8660.642+1.224
TTM1.8660.669+1.197
YOY1.4250.527+0.898
5Y1.3710.666+0.705
10Y0.9990.730+0.269
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Healius generates.

  • Above 15 is considered overpriced but always compare Healius to the Diagnostics & Research industry mean.
  • A PE ratio of -1.69 means the investor is paying $-1.69 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Healius Ltd:

  • The EOD is -1.945. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.687. Based on the earnings, the company is expensive. -2
  • The TTM is -1.687. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.945MRQ-1.687-0.259
MRQ-1.687TTM-1.6870.000
TTM-1.687YOY-5.811+4.124
TTM-1.6875Y8.529-10.216
5Y8.52910Y70.873-62.344
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-1.945-0.412-1.533
MRQ-1.687-0.696-0.991
TTM-1.687-0.715-0.972
YOY-5.811-0.087-5.724
5Y8.5292.156+6.373
10Y70.8733.962+66.911
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Healius Ltd:

  • The EOD is 7.228. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 6.267. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 6.267. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD7.228MRQ6.267+0.961
MRQ6.267TTM6.2670.000
TTM6.267YOY8.310-2.043
TTM6.2675Y6.481-0.214
5Y6.48110Y15.492-9.011
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD7.228-0.582+7.810
MRQ6.267-1.063+7.330
TTM6.267-1.173+7.440
YOY8.310-3.306+11.616
5Y6.481-1.782+8.263
10Y15.492-2.284+17.776
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Healius is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.05 means the investor is paying $1.05 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Healius Ltd:

  • The EOD is 1.207. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.047. Based on the equity, the company is underpriced. +1
  • The TTM is 1.047. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.207MRQ1.047+0.160
MRQ1.047TTM1.0470.000
TTM1.047YOY1.419-0.372
TTM1.0475Y1.297-0.251
5Y1.29710Y1.257+0.040
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD1.2072.287-1.080
MRQ1.0472.093-1.046
TTM1.0472.197-1.150
YOY1.4192.438-1.019
5Y1.2973.753-2.456
10Y1.2574.163-2.906
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Healius Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Long-term Assets Other  -2,040,200-2,100-2,042,300-302,000-2,344,300446,800-1,897,5001,969,30071,800



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets2,982,800
Total Liabilities1,942,100
Total Stockholder Equity1,040,700
 As reported
Total Liabilities 1,942,100
Total Stockholder Equity+ 1,040,700
Total Assets = 2,982,800

Assets

Total Assets2,982,800
Total Current Assets300,100
Long-term Assets2,682,700
Total Current Assets
Cash And Cash Equivalents 60,100
Net Receivables 187,700
Inventory 31,900
Other Current Assets 20,400
Total Current Assets  (as reported)300,100
Total Current Assets  (calculated)300,100
+/-0
Long-term Assets
Property Plant Equipment 1,221,900
Goodwill 1,296,700
Long Term Investments 3,200
Intangible Assets 71,800
Long-term Assets Other 71,800
Long-term Assets  (as reported)2,682,700
Long-term Assets  (calculated)2,665,400
+/- 17,300

Liabilities & Shareholders' Equity

Total Current Liabilities600,300
Long-term Liabilities1,341,800
Total Stockholder Equity1,040,700
Total Current Liabilities
Short-term Debt 271,300
Accounts payable 200,900
Other Current Liabilities 128,100
Total Current Liabilities  (as reported)600,300
Total Current Liabilities  (calculated)600,300
+/- 0
Long-term Liabilities
Long term Debt 420,800
Capital Lease Obligations Min Short Term Debt905,800
Long-term Liabilities  (as reported)1,341,800
Long-term Liabilities  (calculated)1,326,600
+/- 15,200
Total Stockholder Equity
Common Stock2,603,900
Retained Earnings -1,567,300
Accumulated Other Comprehensive Income 5,000
Other Stockholders Equity -900
Total Stockholder Equity (as reported)1,040,700
Total Stockholder Equity (calculated)1,040,700
+/-0
Other
Capital Stock2,603,900
Cash and Short Term Investments 60,100
Common Stock Shares Outstanding 659,800
Current Deferred Revenue0
Liabilities and Stockholders Equity 2,982,800
Net Debt 1,537,800
Net Invested Capital 1,461,500
Net Working Capital -300,200
Property Plant and Equipment Gross 1,581,300
Short Long Term Debt Total 1,597,900



5.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-30
> Total Assets 
40,266
85,908
162,246
220,775
283,354
292,331
302,387
447,901
544,424
606,502
4,798,310
3,778,527
3,696,253
3,825,654
3,861,947
3,984,784
3,742,275
3,918,100
3,624,600
3,114,100
3,126,300
3,352,700
4,588,300
3,782,200
4,136,800
3,653,200
2,982,800
2,982,8003,653,2004,136,8003,782,2004,588,3003,352,7003,126,3003,114,1003,624,6003,918,1003,742,2753,984,7843,861,9473,825,6543,696,2533,778,5274,798,310606,502544,424447,901302,387292,331283,354220,775162,24685,90840,266
   > Total Current Assets 
4,687
8,684
23,855
54,070
66,407
22,113
19,513
31,246
30,892
36,784
1,467,489
411,809
206,561
226,362
201,027
212,401
204,583
310,200
250,300
266,500
287,000
346,500
1,341,600
330,900
371,800
344,300
300,100
300,100344,300371,800330,9001,341,600346,500287,000266,500250,300310,200204,583212,401201,027226,362206,561411,8091,467,48936,78430,89231,24619,51322,11366,40754,07023,8558,6844,687
       Cash And Cash Equivalents 
2,909
343
2,218
18
45
40
747
923
739
780
7,784
223,397
25,812
43,252
10,432
34,725
27,460
50,000
82,300
95,500
84,000
119,700
137,500
70,100
81,300
115,300
60,100
60,100115,30081,30070,100137,500119,70084,00095,50082,30050,00027,46034,72510,43243,25225,812223,3977,7847807399237474045182,2183432,909
       Short-term Investments 
0
0
0
0
-6
0
0
0
0
135
115
6,933
1,500
798
4,574
0
0
3,200
0
0
0
0
0
0
0
0
0
0000000003,200004,5747981,5006,9331151350000-60000
       Net Receivables 
1,778
8,341
11,765
17,696
16,027
19,808
16,330
22,080
23,381
28,590
141,004
156,798
149,727
156,701
158,645
84,901
101,072
102,000
105,100
107,400
160,200
175,200
248,800
184,100
219,700
171,300
187,700
187,700171,300219,700184,100248,800175,200160,200107,400105,100102,000101,07284,901158,645156,701149,727156,798141,00428,59023,38122,08016,33019,80816,02717,69611,7658,3411,778
       Other Current Assets 
0
0
9,872
36,356
48,744
2,265
0
4,829
2,356
2,370
1,297,473
2,965
5,218
0
1,301
66,897
48,789
126,800
37,400
38,500
20,600
28,900
928,400
40,800
21,600
24,900
20,400
20,40024,90021,60040,800928,40028,90020,60038,50037,400126,80048,78966,8971,30105,2182,9651,297,4732,3702,3564,82902,26548,74436,3569,87200
   > Long-term Assets 
35,580
77,224
138,391
166,705
216,947
270,218
282,874
416,655
513,532
569,718
3,330,821
3,366,718
3,489,692
3,599,292
3,660,920
3,718,997
3,466,358
3,589,300
3,336,400
2,793,000
2,709,200
2,887,400
3,246,700
3,451,300
3,765,000
3,308,900
2,682,700
2,682,7003,308,9003,765,0003,451,3003,246,7002,887,4002,709,2002,793,0003,336,4003,589,3003,466,3583,718,9973,660,9203,599,2923,489,6923,366,7183,330,821569,718513,532416,655282,874270,218216,947166,705138,39177,22435,580
       Property Plant Equipment 
9,349
22,237
37,597
42,628
68,487
96,533
94,010
107,027
139,611
151,366
352,809
340,249
379,202
416,744
433,846
409,052
427,922
435,700
342,200
299,000
297,500
327,000
1,043,600
1,244,900
1,270,900
1,243,300
1,221,900
1,221,9001,243,3001,270,9001,244,9001,043,600327,000297,500299,000342,200435,700427,922409,052433,846416,744379,202340,249352,809151,366139,611107,02794,01096,53368,48742,62837,59722,2379,349
       Goodwill 
26,200
54,947
100,760
123,495
148,048
172,415
178,465
305,639
326,914
372,255
2,836,728
2,892,701
2,999,778
3,081,598
3,138,713
3,213,162
2,798,239
2,832,100
2,772,200
2,315,500
2,348,700
2,482,500
2,040,200
2,042,300
2,344,300
1,897,500
1,296,700
1,296,7001,897,5002,344,3002,042,3002,040,2002,482,5002,348,7002,315,5002,772,2002,832,1002,798,2393,213,1623,138,7133,081,5982,999,7782,892,7012,836,728372,255326,914305,639178,465172,415148,048123,495100,76054,94726,200
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36,200
1,300
11,900
10,500
600
1,200
5,600
5,800
7,100
3,200
3,2007,1005,8005,6001,20060010,50011,9001,30036,20000000000000000000
       Intangible Assets 
26,200
54,947
100,760
123,495
148,048
172,415
178,465
305,639
40,224
39,919
75,363
68,956
64,157
63,508
65,313
68,354
212,567
285,300
220,700
166,600
63,000
77,900
2,119,500
2,118,600
2,419,500
1,970,600
71,800
71,8001,970,6002,419,5002,118,6002,119,50077,90063,000166,600220,700285,300212,56768,35465,31363,50864,15768,95675,36339,91940,224305,639178,465172,415148,048123,495100,76054,94726,200
       Other Assets 
0
0
34
0
0
1,059
988
3,823
3,259
3,738
65,226
68,041
54,864
55,138
50,412
53,386
71,334
18,600
37,900
54,600
130,100
118,800
82,400
0
74,600
0
0
0074,600082,400118,800130,10054,60037,90018,60071,33453,38650,41255,13854,86468,04165,2263,7383,2593,8239881,059003400
> Total Liabilities 
14,758
38,899
51,993
109,442
110,815
106,044
103,833
127,888
152,009
197,096
3,037,165
1,661,823
1,226,016
1,321,265
1,288,834
1,305,919
1,371,167
1,502,700
1,196,900
1,245,000
1,307,400
1,301,600
2,657,000
1,924,900
2,215,200
2,147,000
1,942,100
1,942,1002,147,0002,215,2001,924,9002,657,0001,301,6001,307,4001,245,0001,196,9001,502,7001,371,1671,305,9191,288,8341,321,2651,226,0161,661,8233,037,165197,096152,009127,888103,833106,044110,815109,44251,99338,89914,758
   > Total Current Liabilities 
4,187
18,850
19,249
31,172
18,158
16,464
14,045
44,392
36,161
36,441
2,973,386
1,615,889
174,761
177,978
196,219
219,581
254,217
428,700
280,800
331,600
374,900
392,600
995,300
684,700
641,300
629,600
600,300
600,300629,600641,300684,700995,300392,600374,900331,600280,800428,700254,217219,581196,219177,978174,7611,615,8892,973,38636,44136,16144,39214,04516,46418,15831,17219,24918,8504,187
       Short-term Debt 
1,432
2,384
6,235
23,338
3,783
1,259
83
5,482
9,628
6,240
2,196,419
1,432,261
4,142
3,754
3,804
3,346
3,072
167,277
2,000
300
800
600
173,900
224,400
223,700
263,000
271,300
271,300263,000223,700224,400173,9006008003002,000167,2773,0723,3463,8043,7544,1421,432,2612,196,4196,2409,6285,482831,2593,78323,3386,2352,3841,432
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
167,000
1,900
800
500
6,900
9,500
5,600
0
0
0
0005,6009,5006,9005008001,900167,00000000000000000000
       Accounts payable 
2,754
3,709
3,983
3,940
4,248
5,382
5,690
13,848
12,538
13,839
97,357
106,517
88,234
122,503
119,807
97,769
103,296
139,000
156,500
203,300
209,200
222,900
203,000
205,900
169,600
218,000
200,900
200,900218,000169,600205,900203,000222,900209,200203,300156,500139,000103,29697,769119,807122,50388,234106,51797,35713,83912,53813,8485,6905,3824,2483,9403,9833,7092,754
       Other Current Liabilities 
3,057
15,141
15,266
1,258
2,134
4,002
4,365
12,610
8,145
10,835
667,659
66,856
67,961
41,771
10,966
121,812
150,921
289,700
115,800
121,300
164,800
169,700
579,000
207,600
180,700
146,700
128,100
128,100146,700180,700207,600579,000169,700164,800121,300115,800289,700150,921121,81210,96641,77167,96166,856667,65910,8358,14512,6104,3654,0022,1341,25815,26615,1413,057
   > Long-term Liabilities 
10,571
20,049
32,744
78,270
92,657
89,580
89,788
83,496
115,848
160,655
63,779
45,934
1,051,255
1,143,287
1,092,615
1,076,634
1,099,924
1,057,300
897,100
879,400
861,700
812,300
1,661,700
1,240,200
1,573,900
1,517,400
1,341,800
1,341,8001,517,4001,573,9001,240,2001,661,700812,300861,700879,400897,1001,057,3001,099,9241,076,6341,092,6151,143,2871,051,25545,93463,779160,655115,84883,49689,78889,58092,65778,27032,74420,04910,571
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,050,000
896,300
879,400
860,000
797,300
1,574,000
1,211,300
1,555,300
1,503,000
0
01,503,0001,555,3001,211,3001,574,000797,300860,000879,400896,3001,050,00000000000000000000
       Other Liabilities 
0
0
772
1,316
1,303
947
898
2,307
2,553
2,030
60,468
43,620
50,582
29,456
20,787
13,930
22,397
16,700
19,000
34,000
69,900
96,500
74,200
22,500
18,600
14,400
0
014,40018,60022,50074,20096,50069,90034,00019,00016,70022,39713,93020,78729,45650,58243,62060,4682,0302,5532,3078989471,3031,31677200
> Total Stockholder Equity
25,508
47,009
110,253
111,333
172,539
186,287
198,554
320,013
392,415
408,984
1,757,166
2,113,112
2,465,815
2,499,389
2,567,786
2,677,105
2,369,330
2,413,600
2,426,100
1,867,600
1,818,900
2,051,100
1,931,300
1,857,300
1,921,600
1,506,200
1,040,700
1,040,7001,506,2001,921,6001,857,3001,931,3002,051,1001,818,9001,867,6002,426,1002,413,6002,369,3302,677,1052,567,7862,499,3892,465,8152,113,1121,757,166408,984392,415320,013198,554186,287172,539111,333110,25347,00925,508
   Common Stock
10,706
46,046
109,314
110,084
171,530
175,596
181,444
292,449
300,369
310,834
1,705,351
1,995,264
2,318,578
2,337,758
2,349,364
2,358,183
2,366,276
2,407,300
2,422,800
2,422,800
2,424,200
2,671,100
2,672,300
2,575,600
2,422,900
2,421,000
2,603,900
2,603,9002,421,0002,422,9002,575,6002,672,3002,671,1002,424,2002,422,8002,422,8002,407,3002,366,2762,358,1832,349,3642,337,7582,318,5781,995,2641,705,351310,834300,369292,449181,444175,596171,530110,084109,31446,04610,706
   Retained Earnings 
479
963
939
1,249
1,009
10,691
17,110
27,564
87,272
93,402
44,241
109,087
138,867
154,251
221,951
309,659
-4,919
12,200
8,500
-565,700
-618,200
-612,400
-737,600
-731,600
-521,200
-923,300
-1,567,300
-1,567,300-923,300-521,200-731,600-737,600-612,400-618,200-565,7008,50012,200-4,919309,659221,951154,251138,867109,08744,24193,40287,27227,56417,11010,6911,0091,249939963479
   Accumulated Other Comprehensive Income 
14,323
-5,965
-10,375
-12,172
-19,984
-28,337
-38,833
-47,355
4,774
4,748
7,574
8,761
8,370
7,380
-3,529
9,263
7,973
-5,901
-5,200
10,500
12,900
-8,000
-3,400
16,900
19,900
8,500
5,000
5,0008,50019,90016,900-3,400-8,00012,90010,500-5,200-5,9017,9739,263-3,5297,3808,3708,7617,5744,7484,774-47,355-38,833-28,337-19,984-12,172-10,375-5,96514,323
   Capital Surplus 000000000000000000000000000
   Treasury Stock000-3,60000000000000000000000000
   Other Stockholders Equity 
0
5,965
10,375
12,172
19,984
28,337
0
0
0
0
0
0
0
0
0
0
0
-5,900
-5,200
10,500
12,900
-7,600
-1,934,700
-3,600
-1,901,700
-1,497,700
-900
-900-1,497,700-1,901,700-3,600-1,934,700-7,60012,90010,500-5,200-5,9000000000000028,33719,98412,17210,3755,9650



5.4. Balance Sheets

Currency in AUD. All numbers in thousands.